Endophyte-enhanced banana plantlets for TR4 resistance and sustainable production

Overview

This solution addresses the critical threat of Tropical Race 4 (TR4), a devastating fungal disease that has caused widespread losses in global banana production. The approach involves inserting novel endophytic bacteria into banana plantlets to create 'banana hybrids' with built-in disease resistance. By establishing beneficial microorganisms directly within the plant tissue, the technology provides durable TR4 resistance while supporting sustainable banana cultivation. The solution is designed to be affordable and scalable across banana-producing countries, making it accessible to growers in diverse agricultural contexts.

Technical specifications

The technology leverages three identified endophytic bacterial isolates (YN1419, YN1910, and YN1282-2) that demonstrate strong antagonism against TR4.

Key features:

• TR4 inhibition rates of 78.0%, 79.6%, and 81.3% respectively for the three isolates
• Greenhouse control effects of 67.7%, 82.6%, and 85.6% respectively against TR4 infection
• Growth promotion of banana plantlets observed alongside disease resistance
• Optimized fluorescent electro-transformation system for TR4-inhibitory Bacillus spp. strains
• Colonization capability confirmed via Scanning Electron Microscopy showing Bacillus spp. colonizing banana root xylem cells
• Chemotaxis behavior demonstrated through Laser Scanning Confocal Microscopy, with RFP-labelled bacteria moving toward GFP-labelled TR4 pathogen hyphae
• Biocontrol marker genes detected for antibiotic biosynthesis and auxin key synthetase production
• Tritrophic biocontrol system (host-pathogen-endophyte) designed to ensure disease containment even when TR4 is present

Technology readiness level

The technology has completed initial laboratory validation and greenhouse testing with strong demonstrated results. Three endophytic isolates have been identified and characterized for their TR4-inhibitory properties and plant growth promotion capabilities. Future validation requires optimizing the insertion protocol under laboratory conditions, refining the greenhouse nursing system, and conducting field trials in TR4-infected areas to monitor both disease resistance and productivity over an approximately two-year period. The solution is currently at a stage ready for collaborative field validation and scale-up partnerships.